ZRANB2-AS1: A Potential Drug Target and Biomarker (G100132618)

Target Name: ZRANB2-AS1

NCBI ID: G100132618

ZRANB2-AS1

Other Name(s): ZRANB2 antisense RNA 1

ZRANB2-AS1: A Potential Drug Target and Biomarker

Zinc finger RNA binding proteins (ZFPs) are a family of non-coding RNAs that play a crucial role in post-transcriptional gene regulation. ZFPs have been identified as potential drug targets in various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. One of the most promising ZFP is ZRANB2-AS1, which has been identified as a potential drug target and biomarker for various diseases.

ZRANB2-AS1: Structure and Function

ZRANB2-AS1 is a ZFP that consists of 219 amino acid residues. It has a characteristic ZNF2-like domain and a conserved N-terminal region that is similar to ZNF2. ZRANB2-AS1 is expressed in various tissues and has been shown to play a role in various physiological processes, including cell growth, differentiation, and RNA homeostasis.

One of the most significant features of ZRANB2-AS1 is its ability to interact with small molecules, including drugs. This interaction makes ZRANB2-AS1 a potential drug target. ZRANB2-AS1 has been shown to be sensitive to various small molecules, including inhibitors, toxins, and drugs that target its amino acid residues.

Drug Sensitivity Assays

To determine the drug sensitivity of ZRANB2-AS1, several experiments have been performed. In cell-based assays, ZRANB2-AS1 was shown to be sensitive to inhibitors of its activity, including inhibitors of RNA binding and protein-protein interactions. In live cell imaging experiments, ZRANB2-AS1 was also shown to be sensitive to inhibitors that targeted its amino acid residues. These results suggest that ZRANB2-AS1 may be a drug target that can be targeted by small molecules.

Biomarker Assays

To determine the potential utility of ZRANB2-AS1 as a biomarker, several experiments have been performed. In cell-based assays, ZRANB2-AS1 was shown to be expressed in various tissues and to be sensitive to small molecules that interact with its amino acid residues. In tissue sections, ZRANB2-AS1 was shown to be expressed in various tissues and to be sensitive to small molecules that interact with its amino acid residues. These results suggest that ZRANB2-AS1 may be a useful biomarker for identifying diseases associated with its expression.

In conclusion, ZRANB2-AS1 is a ZFP that has been shown to play a role in various physiological processes. Its ability to interact with small molecules makes it a potential drug target. In addition, ZRANB2-AS1 has also been shown to be expressed in various tissues and to be sensitive to small molecules that interact with its amino acid residues, which makes it a potential biomarker. Further research is needed to determine the full utility of ZRANB2-AS1 as a drug target and biomarker.

Protein Name: ZRANB2 Antisense RNA 1

The "ZRANB2-AS1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZRANB2-AS1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets